Atricure (ATRC) Stock Rose While Wellington Management Group Llp Upped Its Stake; Cognizant Technology Solutio (CTSH) Shares Rose While Whitnell & Co Has Raised by $470,232 Its Holding

January 14, 2018 - By Dolores Ford

Wellington Management Group Llp increased its stake in Atricure Inc (ATRC) by 85.46% based on its latest 2017Q3 regulatory filing with the SEC. Wellington Management Group Llp bought 1.74M shares as the company’s stock rose 23.67% with the market. The institutional investor held 3.77M shares of the health care company at the end of 2017Q3, valued at $84.38 million, up from 2.03 million at the end of the previous reported quarter. Wellington Management Group Llp who had been investing in Atricure Inc for a number of months, seems to be bullish on the $611.23M market cap company. The stock increased 0.23% or $0.04 during the last trading session, reaching $17.73. About 160,826 shares traded. AtriCure, Inc. (NASDAQ:ATRC) has risen 53.35% since January 14, 2017 and is uptrending. It has outperformed by 36.65% the S&P500.

Whitnell & Co increased its stake in Cognizant Technology Solutio (CTSH) by 27.71% based on its latest 2017Q3 regulatory filing with the SEC. Whitnell & Co bought 6,531 shares as the company’s stock rose 12.87% with the market. The institutional investor held 30,101 shares of the edp services company at the end of 2017Q3, valued at $2.18 million, up from 23,570 at the end of the previous reported quarter. Whitnell & Co who had been investing in Cognizant Technology Solutio for a number of months, seems to be bullish on the $43.96 billion market cap company. The stock increased 0.74% or $0.55 during the last trading session, reaching $74.56. About 3.82 million shares traded or 7.47% up from the average. Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has risen 5.50% since January 14, 2017 and is uptrending. It has underperformed by 11.20% the S&P500.

Investors sentiment increased to 2.03 in Q3 2017. Its up 0.78, from 1.25 in 2017Q2. It is positive, as 9 investors sold ATRC shares while 21 reduced holdings. 23 funds opened positions while 38 raised stakes. 26.77 million shares or 5.51% more from 25.37 million shares in 2017Q2 were reported. D E Shaw And Com has invested 0% in AtriCure, Inc. (NASDAQ:ATRC). Us National Bank & Trust De invested in 0% or 4,617 shares. Tower Research Cap Limited Liability Com (Trc) owns 5,478 shares. Fmr Lc reported 5.15M shares stake. Prelude Cap Management Limited Liability Corporation has invested 0.03% in AtriCure, Inc. (NASDAQ:ATRC). Lockheed Martin Invest Mngmt reported 36,250 shares. Nuveen Asset Management Ltd Liability Corp holds 0.01% of its portfolio in AtriCure, Inc. (NASDAQ:ATRC) for 52,721 shares. Millennium invested in 0.04% or 1.09 million shares. Sei Invests Communication holds 0% in AtriCure, Inc. (NASDAQ:ATRC) or 9,369 shares. Laurion Management Lp has 0.03% invested in AtriCure, Inc. (NASDAQ:ATRC). Utd Cap Fincl Advisers Limited Liability owns 14,244 shares or 0% of their US portfolio. Nationwide Fund holds 0% or 46,248 shares. Bank Of Mellon Corp has invested 0% of its portfolio in AtriCure, Inc. (NASDAQ:ATRC). Eventide Asset Mgmt Ltd Liability Com holds 180,000 shares. Macquarie Group Ltd owns 82,245 shares.

Among 9 analysts covering Atricure Inc. (NASDAQ:ATRC), 8 have Buy rating, 1 Sell and 0 Hold. Therefore 89% are positive. Atricure Inc. had 29 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Buy” rating by Stifel Nicolaus given on Friday, August 5. The stock has “Outperform” rating by Northland Capital on Tuesday, March 29. The rating was maintained by Canaccord Genuity on Thursday, November 2 with “Buy”. The stock of AtriCure, Inc. (NASDAQ:ATRC) earned “Buy” rating by Leerink Swann on Thursday, June 15. The rating was maintained by Piper Jaffray with “Buy” on Sunday, December 10. Needham maintained AtriCure, Inc. (NASDAQ:ATRC) on Wednesday, October 28 with “Buy” rating. The firm has “Buy” rating by Piper Jaffray given on Friday, July 28. The firm has “Buy” rating by Canaccord Genuity given on Tuesday, October 6. The stock of AtriCure, Inc. (NASDAQ:ATRC) has “Buy” rating given on Friday, July 28 by Needham. The stock has “Sell” rating by UBS on Tuesday, September 22.

Since August 21, 2017, it had 0 buys, and 1 sale for $224,000 activity.

Wellington Management Group Llp, which manages about $435.63 billion US Long portfolio, decreased its stake in Epizyme Inc (NASDAQ:EPZM) by 71,140 shares to 74,762 shares, valued at $1.42M in 2017Q3, according to the filing. It also reduced its holding in Watsco Inc (NYSE:WSO) by 3,479 shares in the quarter, leaving it with 33,176 shares, and cut its stake in Ross Stores Inc (NASDAQ:ROST).

Since August 4, 2017, it had 0 insider buys, and 33 insider sales for $25.05 million activity. $578,169 worth of stock was sold by KRISHNASWAMY VENKAT on Friday, August 11. $31,196 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) shares were sold by Shaheen Allen. Kandiah Gajakarnan Vibushanan had sold 1,954 shares worth $139,248. RAMAKRISHNAN CHANDRASEKARAN sold $1.75 million worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) on Monday, August 28. $182,500 worth of stock was sold by Veeraraghavachary Srinivasan on Tuesday, September 12. The insider CHINTAMANENI RAMAKRISHNA PRASAD sold $393,264.

Whitnell & Co, which manages about $1.15B and $229.40 million US Long portfolio, decreased its stake in Kayne Anderson Mlp Invt Co (NYSE:KYN) by 20,873 shares to 186,525 shares, valued at $3.39 million in 2017Q3, according to the filing.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.27, from 0.76 in 2017Q2. It is positive, as 37 investors sold CTSH shares while 296 reduced holdings. 99 funds opened positions while 244 raised stakes. 487.81 million shares or 3.03% less from 503.05 million shares in 2017Q2 were reported. Everence Cap Mngmt reported 8,415 shares stake. Moreover, Md Sass Invsts Ser has 0.15% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH) for 24,400 shares. Psagot Invest House Ltd reported 0.11% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Capital One Natl Association reported 0.03% of its portfolio in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Harding Loevner LP accumulated 3.54M shares. The Maryland-based Proshare Advisors has invested 0.17% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Ibm Retirement Fund has 14,595 shares. American Co Tx, a Texas-based fund reported 74,017 shares. Winfield Associates Incorporated has 0.01% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Parsec Fincl Mgmt holds 13,366 shares. Nbt Bancshares N A Ny stated it has 0.04% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Williams Jones And Assoc Ltd Liability Com reported 2,830 shares. 93,632 are held by Amica Mutual Ins. Virtus Invest Advisers accumulated 6,023 shares. Moreover, Adell Harriman Carpenter Inc has 0.14% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH).

Among 30 analysts covering Cognizant Technology Solutions Corp. (NASDAQ:CTSH), 23 have Buy rating, 1 Sell and 6 Hold. Therefore 77% are positive. Cognizant Technology Solutions Corp. had 74 analyst reports since August 6, 2015 according to SRatingsIntel. RBC Capital Markets maintained Cognizant Technology Solutions Corporation (NASDAQ:CTSH) on Wednesday, July 12 with “Buy” rating. The firm has “Outperform” rating given on Thursday, August 6 by BMO Capital Markets. The firm has “Buy” rating by Cowen & Co given on Wednesday, September 6. The firm earned “Outperform” rating on Tuesday, February 9 by RBC Capital Markets. On Tuesday, January 10 the stock rating was initiated by Loop Capital with “Hold”. The firm earned “Buy” rating on Friday, September 8 by Robert W. Baird. SunTrust upgraded the stock to “Buy” rating in Thursday, April 13 report. The firm earned “Outperform” rating on Friday, January 6 by Wedbush. The firm earned “Neutral” rating on Monday, October 3 by Citigroup. The company was initiated on Friday, September 9 by Wedbush.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>